Article
Therapeutic effects of favipiravir against severe fever with thrombocytopenia syndrome virus infection in a lethal mouse model: dose-efficacy studies upon oral administration
2018-08-24
Abstract excerpt
<h4>Background</h4> Severe fever with thrombocytopenia syndrome (SFTS), caused by SFTS virus (SFTSV), is a viral hemorrhagic fever with a high case fatality rate. Favipiravir was reported to be effective in the treatment of SFTSV infection in vivo in type I interferon receptor knockout (IFNAR -/- ) mice at treatment dosages of both 60 mg/kg/day and 300 mg/kg/day for a duration of 5 days. <h4>Methods</h4> In t...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f256c0f4-0f19-53f7-98e0-ae98dbbd658d
- DOI
- 10.1101/399899
